MENU

GALT Galectin Therapeutics Forecast, Technical & Fundamental Analysis

a developer of drugs to combat various diseases

Industry Biotechnology
GALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
GALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GALT is expected to report earnings to fall 15.79% to -15 cents per share on August 12

Galectin Therapeutics GALT Stock Earnings Reports
Q2'24
Est.
$-0.16
Q1'24
Missed
by $0.03
Q4'23
Missed
by $0.06
Q3'23
Missed
by $0.14
Q2'23
Missed
by $0.01
The last earnings report on May 15 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 33.80K shares outstanding, the current market capitalization sits at 158.48M.
A.I. Advisor
published General Information

General Information

a developer of drugs to combat various diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WIGRX92.741.69
+1.86%
Wasatch Core Growth Institutional
TSLAX5.98N/A
N/A
Transamerica Small Cap Value A
DGIEX20.21N/A
N/A
BNY Mellon Global Emerging Mkts - I
REGIX7.47N/A
N/A
Regnan Global Equity Impact Sol Instl
AWACX21.28-0.16
-0.75%
AB Wealth Appreciation Strategy C

GALT and Stocks

Correlation & Price change

A.I.dvisor tells us that GALT and SNPX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GALT and SNPX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GALT
1D Price
Change %
GALT100%
-1.16%
SNPX - GALT
32%
Poorly correlated
+0.49%
RNAC - GALT
32%
Poorly correlated
+1.04%
RNAZ - GALT
27%
Poorly correlated
+3.03%
VINC - GALT
26%
Poorly correlated
+1.47%
IRON - GALT
25%
Poorly correlated
-1.62%
More